Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AlzProtect SAS

www.alzprotect.com

Latest From Allergan PLC

Neuralstem Plans Deep Dive Into Failed Phase II Major Depression Trial

Failure of stem cell therapy NSI-189 in major depression study sends stock price down about 50% and next steps for development are unclear.

Neurology Clinical Trials

Apollo Endosurgery Seeks To Raise $31m In Share Sale

Anti-obesity device company Apollo Endosurgery is looking to net around $31m through a sale of 5.7 million shares. The Austin, Texas-based company has seen slow sales in the last couple of years and is planning to use the funds to boost adoption of its endo-bariatric products, which includes the Orbera intragastric balloon and the Lap-Band gastric band which it inherited through acquiring Allergan’s obesity intervention division in 2013.

Financing Deals

AbbVie AndroGel Jury Verdict Targets 'Low T' Promotion

In first bellwether trial in testosterone replacement therapy litigation, jury issues $150m verdict against AbbVie for fraudulent misrepresentation of AndroGel.

BioPharmaceutical Policy

2Q Pharma Results Preview: Lilly, Biogen, Amgen, GSK And Gilead

Part two of Scrip's preview of first quarter earnings: product launches, management priorities, pricing strategies and biosimilar competition are key themes at the half-year mark.

Sales & Earnings Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • AlzProtect SAS
  • Senior Management
  • Philippe Verwaerde, PhD, Pres., CEO & CSO
  • Contact Info
  • AlzProtect SAS
    Phone: (33) 320 29088 61
    Batiment Biserte, 1 Place de Verdun
    rue Polonovski
    Lille, 59045
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register